Modelled DT Structure
Method:homology modeling
Template PDB:6V4D_A
Identity:41.164%
Minimized Score:-1038.125 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0118 | ||||
Gene Name | SLC17A5 | ||||
Protein Name | Vesicular H(+)/Aspartate-glutamate cotransporter | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method:homology modeling Template PDB:6V4D_A Identity:41.164% Minimized Score:-1038.125 kcal/mol Detail: Structure Info |
||||
Synonyms | AST; H(+)/nitrate cotransporter; ISSD; Membrane glycoprotein HP59; NSD; SD; SIASD; SLC17A5; SLD; Sialin; Solute carrier family 17 member 5; H(+)/sialic acid cotransporter | ||||
DT Family | Major Facilitator Superfamily (MFS) | ||||
Anion:Cation Symporter (ACS) Family | |||||
Tissue Specificity | Found in fetal lung and small intestine, andat lower level in fetal skin and muscle. In the adult, detected inplacenta, kidney and pancreas. Abundant in the endothelial cellsof tumors from ovary, colon, breast and lung, but is not detectedin endothelial cells from the corresponding normal tissues. | ||||
Function | This transporter mediates aspartate and glutamate membrane potential-dependent uptake into synaptic vesicles and synaptic-like microvesicles. It also functions as an electrogenic 2NO(3)(-)/H(+) cotransporter in the plasma membrane of salivary gland acinar cells, mediating the physiological nitrate efflux, 25% of the circulating nitrate ions is typically removed and secreted in saliva. | ||||
Endogenous Substrate(s) | Sialic acid | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 4.0) |
|||||
(α) Tissue Distribution Level of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(β) Cell Distribution Level of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(γ) Organelle Distribution Level of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
Regulatory Variability Data of This DT |
|||||
(β) Post-translational Modification of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(γ) Transcriptional Regulation of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(δ) Epigenetic Regulation of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(ε) Exogenous Modulation of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
Structural Variability Data of This DT |
|||||
(α) Mutation-induced Structural Variation |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT |
|||||
(α) Genetic Polymorphisms of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(β) Disease-specific Protein Abundances of Vesicular H(+)/Aspartate-glutamate cotransporter |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
N-acetylaspartylglutamate
|
Phase 4 | Drug Info | Vernal Keratoconjunctivitis | 9A60.5 | [1] |
Nitrate
|
Phase 4 | Drug Info | Stable angina | BA40.1 | [2] |
Drug-DT Affinity Assessed by Cell Line |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
N-acetylaspartylglutamate | Phase 4 | Drug Info | Proteoliposomes-Sialin | Km =200 microM | [1] |
N-acetylaspartylglutamate | Phase 4 | Drug Info | Proteoliposomes-Sialin | Km =200 microM | [1] |
References | |||||
1 | Vesicular uptake of N-acetylaspartylglutamate is catalysed by sialin (SLC17A5). Biochem J. 2013 Aug 15;454(1):31-8. | ||||
2 | Sialin (SLC17A5) functions as a nitrate transporter in the plasma membrane. Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13434-9. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.